Detection of aberrant methylation as a tumor marker in serum of patients with gastric cancer

Anticancer Research

Volumn 24, Issue 4, 2004, Pages 2477-2481

  Ichikawa, Daisuke ^a   Koike, Hiroshi ^a   Ikoma, Hisashi ^a   Ikoma, Daito ^a   Tani, Nobuyuki ^a   Otsuji, Eigo ^a   Kitamura, Kazuya ^a   Yamagishi, Hisakazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Gastric cancer; Hypermethylation; Methylation specific polymerase chain reaction; Tumor marker

Indexed keywords

DNA; PROTEIN P16; TUMOR MARKER; UVOMORULIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER DIAGNOSIS; E CADHERIN GENE; EARLY CANCER; EARLY DIAGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METHYLATION; POLYMERASE CHAIN REACTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROMOTER REGION; RECURRENT CANCER; STOMACH CANCER; TUMOR SUPPRESSOR GENE;

AGED; CADHERINS; DNA METHYLATION; DNA, NEOPLASM; FEMALE; GENES, P16; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROMOTER REGIONS (GENETICS); STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 4444320810     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Maruyama K, Okabayashi K and Kinoshita Y: Prognosis in gastric cancer in Japan and its limits of radicality. World J Surg 11: 418-425, 1987.
2. Baba H, Korenaga D, Okamura T et al: Prognostic factors in gastric cancer with serosal invasion. Univariate and multivariate analyses. Arch Surg 124: 1061-1064, 1989.
3. Tuech JJ, Cervi C, Pessaux P et al: Early gastric cancer: univariate and multivariate analysis for survival. Hepatogastroenterology 46: 3276-3280, 1999.
4. Pectasides D, Mylonakis A, Kostopoulou M et al: CEA, CA19-9, and CA-50 in monitoring gastric carcinoma. Am J Clin Oncol 20: 348-353, 1997.
5. Marrelli D, Pinto E, De Stefano A et al: Clinical utility of CEA, CA19-9, and CA72-4 in the follow-up patients with resectable gastric cancer. Am J Surg 181: 16-19, 2001.
6. Gerhard M, Juhl H, Kothoff H et al: Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J Clin Oncol 12: 725-729, 1994.
7. Soeth E, Vogel I, Roder C et al: Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR. Cancer Res 57: 3106-3110, 1997.
8. Raj GV, Mereno JG and Gomella LG: Utilization of polymerase chain reaction technology in the detection of solid tumor. Cancer 82: 1419-1442, 1998.
9. Ichikawa D, Kitamura K, Tani N et al: Molecular detection of disseminated cancer cells in the peripheral blood and expression of sialylated antigens in colon cancers. J Surg Oncol 75: 98-102, 2000.
10. Nishida S, Kitamura K, Ichikawa D et al: Molecular detection of disseminated cancer cells in the peripheral blood of patients with gastric cancer. Anticancer Res 20: 2155-2159, 2000.
11. Leon SA, Shapiro B, Sklaroff DM and Yaros MJ: Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 37: 646-650, 1977.
12. Fournie GJ, Courtin JP, Laval F et al: Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours. Cancer Lett 91: 221-227, 1995.
13. Machado JC, Oliveira C, Carvalho R et al: E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene 20: 1525-1528, 2001.
14. Oue N, Motoshita J, Yokozaki H et al: Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas. J Pathol 198: 55-59, 2002.
15. Herman JG, Graff JR, Myohanen S et al: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821-9826, 1996.
16. Sanchez-Cespedes M, Esteller M, Wu L et al: Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res 60: 892-895, 2000.
17. Wong IH, Lo YM, Yeo W et al: Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients. Clin Cancer Res 6: 3516-3521, 2000.
18. Hibi K, Taguchi M, Nakayama H et al: Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma. Clin Cancer Res 7: 3135-3138, 2001.
19. Zou HZ, Yu BM, Wang ZW et al: Detection of aberrant p16 methylation in the serum of colorectal cancer patients. Clin Cancer Res 8: 188-191, 2002.
20. Lee TL, Leung WK, Chan MWY et al: Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma. Clin Cancer Res 8: 1761-1766, 2002.
21. Japanese Gastric Cancer Association: Japanese Classification of Gastric Carcinoma: 2nd English Edition. Gastric Cancer 1: 10-24, 1998.
22. Sorenson GD: Detection of mutated KRAS sequences as tumor markers in plasma/serum of patients with gastrointestinal cancer. Clin Cancer Res 6: 2129-2137, 2000.
23. Mulcahy H, Lyautey J, Lederrey C et al: A prospective study of K-ras mutations in the plasma of pancreatic cancer patients. Clin Cancer Res 4: 271-275, 1998.
24. Yamada T, Nakamori S, Ohzato H et al: Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinomas: correlation with clinicopathological features. Clin Cancer Res 4: 1527-1532, 1998.